Transgene Biotek Limited (BOM:526139)
2.750
-0.010 (-0.36%)
At close: Mar 10, 2026
Transgene Biotek Market Cap
Transgene Biotek has a market cap or net worth of 208.37 million as of March 10, 2026. Its market cap has decreased by -34.52% in one year.
Market Cap
208.37M
Enterprise Value
372.81M
Revenue
2.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.75
Market Cap Chart
Since January 3, 2005, Transgene Biotek's market cap has decreased from 1.43B to 208.37M, a decrease of -85.44%. That is a compound annual growth rate of -8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 208.37M | -12.70% |
| Dec 31, 2025 | 238.68M | -53.88% |
| Dec 31, 2024 | 517.51M | -30.80% |
| Dec 29, 2023 | 747.85M | 234.58% |
| Dec 30, 2022 | 223.52M | -33.71% |
| Dec 31, 2021 | 337.18M | -8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MPIL Corporation | 216.40M |
| KCL Infra Projects | 216.21M |
| Balurghat Technologies | 215.86M |
| Soni Medicare | 215.85M |
| Konark Synthetic | 215.77M |
| KJMC Financial Services | 215.64M |
| GSL Securities | 215.51M |
| Epic Energy | 214.83M |